Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease polycystic ovary syndrome
Comorbidity C0023895|liver disease
Sentences 7
PubMedID- 25554608 Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
PubMedID- 24639812 Background: polycystic ovary syndrome (pcos) is highly associated with non-alcoholic fatty liver disease (nafld).
PubMedID- 24246334 Obstructive sleep apnea predisposes to nonalcoholic fatty liver disease in patients with polycystic ovary syndrome.
PubMedID- 25136364 Cannabinoid receptor 1 gene polymorphisms and nonalcoholic fatty liver disease in women with polycystic ovary syndrome and in healthy controls.
PubMedID- 23980352 Objective: to observe the therapeutic effect of resolving method of chinese medicine (cm) on the lipid metabolism in polycystic ovary syndrome (pcos) patients accompanied with non-alcoholic fatty liver disease (nafld), to analyze the correlation between pcos and nafld, and to study its mechanisms.
PubMedID- 26039829 Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome.
PubMedID- 25339805 Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Page: 1